<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:department>Electronics and Computer Science</gtr:department><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/30A429E3-83B7-4E41-99C0-14A144F07DFE"><gtr:id>30A429E3-83B7-4E41-99C0-14A144F07DFE</gtr:id><gtr:name>University of Southampton</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Highfield</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO17 1BJ</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/924BE15C-91F2-4AAD-941A-3F338324B6AE"><gtr:id>924BE15C-91F2-4AAD-941A-3F338324B6AE</gtr:id><gtr:name>ESRC</gtr:name><gtr:address><gtr:line1>Economic and Social Research Council</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:line3>Polaris Way</gtr:line3><gtr:line4>Swindon</gtr:line4><gtr:line5>Wiltshire</gtr:line5><gtr:postCode>SN2 1UJ</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name><gtr:address><gtr:line1>BBSRC</gtr:line1><gtr:line2>Polaris House</gtr:line2><gtr:line3>North Star Avenue</gtr:line3><gtr:line4>Swindon</gtr:line4><gtr:postCode>SN2 1UH</gtr:postCode><gtr:region>South West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>CO_FUNDER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EB4EED18-4D2E-4BF5-B732-A731B1DC6C51"><gtr:id>EB4EED18-4D2E-4BF5-B732-A731B1DC6C51</gtr:id><gtr:name>MRC Protein Phosphorylation Unit</gtr:name><gtr:address><gtr:line1>Department of Biochemistry</gtr:line1><gtr:line2>The University of Dundee</gtr:line2><gtr:line3>MSI/WTB Complex</gtr:line3><gtr:postCode>DD1 5EH</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/0FD01CC2-BEC0-446C-B6B3-492C7AEEBAD6"><gtr:id>0FD01CC2-BEC0-446C-B6B3-492C7AEEBAD6</gtr:id><gtr:name>Southampton General Hospital</gtr:name><gtr:address><gtr:line1>Southampton General Hospital</gtr:line1><gtr:line2>Tremona Road</gtr:line2><gtr:line4>Southampton</gtr:line4><gtr:line5>Hampshire</gtr:line5><gtr:postCode>SO16 6YD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/BB3BA2F7-DB66-4907-A6AA-86328288CCBA"><gtr:id>BB3BA2F7-DB66-4907-A6AA-86328288CCBA</gtr:id><gtr:name>MHS-Electronics UK Ltd</gtr:name><gtr:address><gtr:line1>Cheney Manor Industrial Estate</gtr:line1><gtr:postCode>SN2 2QW</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D3D3F76B-F553-4E47-8D35-A564C748B364"><gtr:id>D3D3F76B-F553-4E47-8D35-A564C748B364</gtr:id><gtr:firstName>Donna</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Davies</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/CE59E4E0-B60A-47F6-A564-802C1597C079"><gtr:id>CE59E4E0-B60A-47F6-A564-802C1597C079</gtr:id><gtr:firstName>Mohammad</gtr:firstName><gtr:otherNames>Mojammel</gtr:otherNames><gtr:surname>Hakim</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/C4EAD0E4-5CAA-4146-BE36-A952F003F177"><gtr:id>C4EAD0E4-5CAA-4146-BE36-A952F003F177</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:otherNames>Janine</gtr:otherNames><gtr:surname>Halford</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/8398C119-DE0B-4888-8BB8-09CCDAEABD19"><gtr:id>8398C119-DE0B-4888-8BB8-09CCDAEABD19</gtr:id><gtr:firstName>Hywel</gtr:firstName><gtr:surname>Morgan</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/78E57BA6-96AB-443D-A64F-3D7494B863BB"><gtr:id>78E57BA6-96AB-443D-A64F-3D7494B863BB</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Roach</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/9E4B38DC-EB99-45A1-A98E-D4BF3109E325"><gtr:id>9E4B38DC-EB99-45A1-A98E-D4BF3109E325</gtr:id><gtr:firstName>Maurits</gtr:firstName><gtr:surname>De Planque</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A087746E-286E-423C-95D0-9E2838993CFF"><gtr:id>A087746E-286E-423C-95D0-9E2838993CFF</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Howarth</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A88065FE-AF19-4064-8919-B986E9BE2FAC"><gtr:id>A88065FE-AF19-4064-8919-B986E9BE2FAC</gtr:id><gtr:firstName>Peter</gtr:firstName><gtr:surname>Ashburn</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FG061696%2F1"><gtr:id>BF58DDBE-080F-4587-9001-AB1A687040DE</gtr:id><gtr:title>Silicon Nanowire Arrays for Viral Infection Markers</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/G061696/1</gtr:grantReference><gtr:abstractText>Laboratory analysis of a clinical sample such as blood serum is a powerful diagnostic tool. It establishes the presence and concentration of a specific biomolecule that correlates with the risk or progression of a particular disease, or with the susceptibility of the disease to a given treatment. Regular screening for a large number of such biomarkers, the discovery of which is a major biomedical research activity, would make the large-scale application of predictive, preventive and personalized medicine a reality. This emphasis on prevention and individualization of healthcare is highly desirable from a socio-economical perspective, but the required increase in the number of laboratory tests (already about a billion per annum in the UK) will be huge and cannot be met with the biochemical analysis methods that are currently employed.The aim of this Grand Challenge project is to develop silicon nanowire arrays, the only technology that has been shown to enable highly specific and ultrasensitive analysis of protein biomarkers with electronic rather than costly optical detection, into a robust user platform for the simultaneous analysis of a large number of biomarkers in the same clinical sample. We will optimize a unique method to fabricate extensive arrays of silicon nanowires with a cost-effective mass-production technology that is similar to that used by the microelectronics industry. The silicon nanowires will be incorporated in an advanced microfluidic matrix that will not only allow the sample volume to be very small (a blood droplet obtained with a simple finger prick could be sufficient), but will also provide the means to divide the nanowire array, which can consist of up to a thousand parallel nanowires, into many individually addressable sets of nanowires. Through appropriate functionalization chemistry, each nanowire set can be made to recognize and quantify a different biomarker, enabling a maximum amount of information to be extracted from a minimal amount of sample.The nanowire devices, including the microfluidics for sample handling, will be developed as a single disposable chip, suitable for the mass production of commercial diagnostic kits. Our industrial partners, one manufacturer and two different end-users, will provide a pronounced commercial perspective to the development of the nanowire platform. For clinically relevant pre-commercialization proof of principle, the project will focus on the analysis of six different protein markers of viral infection and treatment. The project will have unique access to clinical samples -serum and induced sputum- obtained from patients admitted to the Acute Medical Unit at the Southampton General Hospital suffering from acute asthma exacerbations. It will also have access to serum samples from asthmatic volunteers undergoing Phase I clinical trials using inhaled beta-interferon which is being developed for treatment of virus-induced asthma exacerbations.The silicon nanowire technology will enable routine and economical high-throughput biomarker analysis outside the clinical laboratory, providing the technological means for a transition to a healthcare system in which regular screening for complex diseases facilitates prevention and early intervention. Throughout the project we will explore practical questions of implementation during scientific and technological development rather than, as is more commonly the case, after scientific and technological phases have been completed. To achieve this we will engage with the public, healthcare professionals, healthcare managers and policy makers to explore key questions of risk and regulation as well as exploring how this technology might be brought into effective use within established systems of healthcare work and organization.</gtr:abstractText><gtr:fund><gtr:end>2012-10-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2009-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1107762</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>360000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Deposition and etch development for top-down silicon nanowire fabrication (industrially funded project)</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Oxford Instruments Plasma Technology</gtr:fundingOrg><gtr:id>8F1198E7-659F-46B4-92D3-830250B03400</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2011-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>998170</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Low cost nanowire diagnostic platform</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/6061696/1</gtr:fundingRef><gtr:id>2050101D-003D-4699-AE27-5CCD516EBF6B</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>998170</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EPSRC</gtr:description><gtr:end>2015-10-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:fundingRef>EP/K502327/1</gtr:fundingRef><gtr:id>39FCFFC9-1B89-4BC7-A59B-DCDD412A4CB0</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our research findings have been taken up by Sharp Laboratories Europe, who are looking to commercialise our approach.</gtr:description><gtr:firstYearOfImpact>2012</gtr:firstYearOfImpact><gtr:id>8A019E85-2B82-4A76-B361-E5CB22D2F6B8</gtr:id><gtr:impactTypes><gtr:impactType>Economic</gtr:impactType></gtr:impactTypes><gtr:sector>Electronics,Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>Laboratory analysis of a clinical sample such as blood serum is a powerful diagnostic tool. It establishes the presence and concentration of a specific biomolecule that correlates with the risk or progression of a particular disease, or with the susceptibility of the disease to a given treatment. Regular screening for a large number of such biomarkers, the discovery of which is a major biomedical research activity, would make the large-scale application of predictive, preventive and personalized medicine a reality. This emphasis on prevention and individualization of healthcare is highly desirable from a socio-economical perspective, but the required increase in the number of laboratory tests (already about a billion per annum in the UK) will be huge and cannot be met with the biochemical analysis methods that are currently employed.



The aim of this Grand Challenge project was to develop silicon nanowire arrays, the only technology that has been shown to enable highly specific and ultrasensitive analysis of protein biomarkers with electronic rather than costly optical detection, into a robust user platform for the simultaneous analysis of a large number of biomarkers in the same clinical sample. We have developed a unique method to fabricate extensive arrays of polycrystalline silicon nanowires with a cost-effective mass-production technology that is similar to that used for the manufacture of TVs and computer displays. The silicon nanowires have sufficient sensitivity to allow diagnosis using a blood droplet obtained with a simple finger prick. 



We have developed chemical functionalization schemes to convert the nanowires into sensors for two inflammation biomarker proteins, tumor necrosis factor alpha (TNF-alpha) and interleukin-8 (IL-8) by immobilizing antibodies against TNF-alpha and IL-8 onto the nanowires. These devices have been used to measure TNF-alpha and IL-8 in low-ionic strength (0.1mM) phosphate buffer. An increase in normalised conductance was seen for each increase in protein biomarker concentration, thereby demonstrating that the nanowire sensors were successfully sensing the presence of the protein of interest. 



In summary, the silicon nanowire technology seeks to enable routine and economical high-throughput biomarker analysis outside the clinical laboratory, providing the technological means for a transition to a healthcare system in which regular screening for complex diseases facilitates prevention and early intervention.</gtr:description><gtr:exploitationPathways>The research is continuing as part of a TSB/EPSRC project in collaboration with three industrial partners: Sharp Laboratories Europe, Oxford Instruments Plasma Technology and Aptamer Diagnostics. The project seeks to develop a biosensor system that is capable of sensing a panel of biomarkers for the diagnosis and management of respiratory diesease. project will have unique access to clinical samples -serum and induced sputum- obtained from patients admitted to the Acute Medical Unit at the Southampton General Hospital suffering from acute asthma exacerbations. It will also have access to serum samples from asthmatic volunteers undergoing Phase I clinical trials using inhaled beta-interferon which is being developed for treatment of virus-induced asthma exacerbations.</gtr:exploitationPathways><gtr:id>814ADE88-126A-4286-A29F-058956EACC03</gtr:id><gtr:sectors><gtr:sector>Electronics,Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5295B638-9366-489E-9A48-CAC640616606"><gtr:id>5295B638-9366-489E-9A48-CAC640616606</gtr:id><gtr:title>Inflammatory biomarker sensing using rectangular polycrystalline silicon nanowires made by dry etching</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/741901a4b280b73388a3bdd5f0a6d832"><gtr:id>741901a4b280b73388a3bdd5f0a6d832</gtr:id><gtr:otherNames>M. Lombardini (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/52DC7090-5C5B-4C28-8B86-6047DA53FFE0"><gtr:id>52DC7090-5C5B-4C28-8B86-6047DA53FFE0</gtr:id><gtr:title>Effect of an Oxide Cap Layer and Fluorine Implantation on the Metal-Induced Lateral Crystallization of Amorphous Silicon</gtr:title><gtr:parentPublicationTitle>ECS Journal of Solid State Science and Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/001bb014d6a90c99828b31de9ec515c2"><gtr:id>001bb014d6a90c99828b31de9ec515c2</gtr:id><gtr:otherNames>Sun K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1CE6B126-454F-4D49-BBF8-1CDEC2462602"><gtr:id>1CE6B126-454F-4D49-BBF8-1CDEC2462602</gtr:id><gtr:title>Remote plasma enhanced atomic layer deposition of ZnO for thin film electronic applications</gtr:title><gtr:parentPublicationTitle>Microelectronic Engineering</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/991e179ff89dbbe5815ec5dcacc9e5e3"><gtr:id>991e179ff89dbbe5815ec5dcacc9e5e3</gtr:id><gtr:otherNames>Sultan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF3588DB-DBDF-4918-BA1E-CC5B46BF3933"><gtr:id>DF3588DB-DBDF-4918-BA1E-CC5B46BF3933</gtr:id><gtr:title>Rectangular Polysilicon Nanowires by Top-Down Lithography, Dry Etch and Metal-Induced Lateral Crystallization</gtr:title><gtr:parentPublicationTitle>Electrochemical and Solid-State Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/001bb014d6a90c99828b31de9ec515c2"><gtr:id>001bb014d6a90c99828b31de9ec515c2</gtr:id><gtr:otherNames>Sun K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/480E8BEE-DE2F-41B8-9A6E-3C87238E28BF"><gtr:id>480E8BEE-DE2F-41B8-9A6E-3C87238E28BF</gtr:id><gtr:title>Comparison of etches for top-down fabrication of polycrystalline silicon nanowires</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a1abe3c3e72a979fc564102145cbb750"><gtr:id>a1abe3c3e72a979fc564102145cbb750</gtr:id><gtr:otherNames>K. Sun (Author)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4EA7587B-0766-4955-8D3A-44A7E4EC81C9"><gtr:id>4EA7587B-0766-4955-8D3A-44A7E4EC81C9</gtr:id><gtr:title>Thin film polycrystalline silicon nanowire biosensors.</gtr:title><gtr:parentPublicationTitle>Nano letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/883b5b82a5ec90c314431c2edaeb5cf3"><gtr:id>883b5b82a5ec90c314431c2edaeb5cf3</gtr:id><gtr:otherNames>Hakim MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1530-6984</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D4680173-E4A6-4839-8494-2235F05DB3BB"><gtr:id>D4680173-E4A6-4839-8494-2235F05DB3BB</gtr:id><gtr:title>Electrical Characteristics of Top-Down ZnO Nanowire Transistors Using Remote Plasma ALD</gtr:title><gtr:parentPublicationTitle>IEEE Electron Device Letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/991e179ff89dbbe5815ec5dcacc9e5e3"><gtr:id>991e179ff89dbbe5815ec5dcacc9e5e3</gtr:id><gtr:otherNames>Sultan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E1EDBD97-9BA8-4216-9C52-BD37602388A6"><gtr:id>E1EDBD97-9BA8-4216-9C52-BD37602388A6</gtr:id><gtr:title>Top-down fabricated ZnO nanowire transistors for application in biosensors</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/991e179ff89dbbe5815ec5dcacc9e5e3"><gtr:id>991e179ff89dbbe5815ec5dcacc9e5e3</gtr:id><gtr:otherNames>Sultan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:isbn>978-1-4673-1707-8</gtr:isbn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21E4A3F1-89C1-4F35-9BC5-465F9D1FC778"><gtr:id>21E4A3F1-89C1-4F35-9BC5-465F9D1FC778</gtr:id><gtr:title>Effect of Fluorine on the Lateral Crystallization of Amorphous Silicon Nanowires</gtr:title><gtr:parentPublicationTitle>ECS Journal of Solid State Science and Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/001bb014d6a90c99828b31de9ec515c2"><gtr:id>001bb014d6a90c99828b31de9ec515c2</gtr:id><gtr:otherNames>Sun K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/G061696/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>16595C3C-600D-4AD2-B394-16E06F96495F</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Med.Instrument.Device&amp; Equip.</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>